The Effects of an Increase in Endogenous Oestrogen on the Haemostatic Mechanism
暂无分享,去创建一个
J. Davies | G. Mcnicol | K. Hancock | J. Toy
[1] A. Quick,et al. A Study of the Coagulation Defect in Hemophilia and in Jaundice , 1935, Thrombosis and Haemostasis.
[2] L. Poller,et al. Conjugated equine oestrogens and blood clotting: a follow-up report. , 1977, British medical journal.
[3] G. Mcnicol,et al. The Effects of Therapy with Oestriol Succinate and Ethinyl Oestradiol on the Haemostatic Mechanism in Post-Menopausal Women , 1976, Thrombosis and Haemostasis.
[4] M. Notelovitz,et al. Natural estrogen and anti-thrombin III activity in postmenopausal women. , 1976, The Journal of reproductive medicine.
[5] M. Notelovitz,et al. The effect of natural oestrogens on coagulation. , 1975, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[6] J. Davies,et al. The effect of aspirin on the exercise-induced changes in platelet function and blood coagulation. , 1974, Thrombosis research.
[7] P. Howie,et al. A Method of Antithrombin Estimation using Plasma Defibrinated with Ancrod , 1973, British journal of haematology.
[8] R. Biggs. Human blood coagulation, haemostasis and thrombosis; , 1972 .
[9] C. Horne,et al. Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity. , 1970, Lancet.
[10] P. Wolf. ORAL CONTRACEPTIVES AND LOW ANTITHROMBIN-III ACTIVITY , 1970 .
[11] M. Elder,et al. Plasma factor IX levels in patients given hexoestrol or stilboestrol to suppress lactation , 1969, British medical journal.
[12] A. S. Douglas,et al. Fibrinolytic Enzyme System and Pregnancy , 1969, British medical journal.
[13] C. Mielke,et al. The standardized normal Ivy bleeding time and its prolongation by aspirin. , 1969, Blood.
[14] P. Didisheim,et al. Platelet adhesiveness in von Willebrand's disease. , 1969, American journal of clinical pathology.
[15] R. Doll,et al. Investigation of Relation between Use of Oral Contraceptives and Thromboembolic Disease. A Further Report , 1969, British medical journal.
[16] J. Ygge,et al. Changes in blood coagulation and fibrinolysis in women receiving oral contraceptives , 1969 .
[17] J. Starup,et al. The coagulation mechanism in oral contraception. , 1967, Acta obstetricia et gynecologica Scandinavica.
[18] L. Poller,et al. Clotting Factors during Oral Contraception: Further Report , 1966, British medical journal.
[19] S. P. Miller,et al. PROGESTIN-ESTROGEN (SC 11,800) THERAPY AND THE HEMOSTATIC MECHANISM--A CONTROLLED STUDY. , 1965, Metabolism: clinical and experimental.
[20] G. Pincus,et al. EFFECTS OF ENOVID ON BLOOD CLOTTING FACTORS. , 1965, Metabolism: clinical and experimental.
[21] C. Hougie,et al. EFFECT OF A PROGESTIN-ESTROGEN ORAL CONTRACEPTIVE ON BLOOD CLOTTING FACTORS. , 1965, Metabolism: clinical and experimental.
[22] L. Talbert,et al. NORMAL VALUES OF CERTAIN FACTORS IN THE BLOOD CLOTTING MECHANISM IN PREGNANCY. , 1964, American journal of obstetrics and gynecology.
[23] G. Born,et al. The aggregation of blood platelets , 1963, The Journal of physiology.
[24] A. S. Douglas,et al. In-vitro and In-vivo Studies of a Preparation of Urokinase , 1963, British medical journal.
[25] L. Pechet,et al. Increased clotting factors in pregnacy. , 1961, The New England journal of medicine.
[26] A. Fletcher,et al. The mechanism of clot dissolution by plasmin. , 1959, The Journal of clinical investigation.
[27] O. Ratnoff,et al. A new method for the determination of fibrinogen in small samples of plasma. , 1951, The Journal of laboratory and clinical medicine.